Preservative-Free versus Benzalkonium Chloride-Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial.

MLA

Bacharach, Jason, et al. “Preservative-Free versus Benzalkonium Chloride-Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial.” Clinical Ophthalmology (Auckland, N.Z.), vol. 17, Sept. 2023, pp. 2575–88. EBSCOhost, https://doi.org/10.2147/OPTH.S414015.

APA

Bacharach, J., Ahmed, I. I. K., Sharpe, E. D., Korenfeld, M. S., Zhang, S., & Baudouin, C. (2023). Preservative-Free versus Benzalkonium Chloride-Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial. Clinical Ophthalmology (Auckland, N.Z.), 17, 2575–2588. https://doi.org/10.2147/OPTH.S414015

Chicago

Bacharach, Jason, Iqbal Ike K Ahmed, Elizabeth D Sharpe, Michael S Korenfeld, Steven Zhang, and Christophe Baudouin. 2023. “Preservative-Free versus Benzalkonium Chloride-Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial.” Clinical Ophthalmology (Auckland, N.Z.) 17 (September): 2575–88. doi:10.2147/OPTH.S414015.